Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases [0.03%]
血清神经丝轻链检测作为多发性硬化生物标志物的价值：西班牙神经病学学会多发性硬化及关联神经免疫疾病研究组共识意见书
J M García Domínguez,L María Villar,G Arrambide et al.
J M García Domínguez et al.
Introduction: Multiple sclerosis (MS) is an inflammatory, degenerative disease of the central nervous system with a complex and uncertain etiology. Although therapeutic advances have improved disease control, both prognos...
Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion [0.03%]
FGF14 GAA扩增所致下向眼震伴共济失调患者长期使用氨吡啶类药物的疗效分析
E Muñoz,M De la Cruz-Puebla,D Pellerin et al.
E Muñoz et al.
Background: Ataxia with downbeat nystagmus (A-DBN) has recently been associated with an intronic GAA repeat expansion in the FGF14 gene. The objectives of our study were to describe the clinical, radiological, and genetic...
Old drugs, new indications: Effectiveness of amantadine for epileptic encephalopathy in paediatric patients with spike-wave activation in sleep or refractory absence seizures [0.03%]
老药新用：金刚烷胺对儿童睡眠棘波激活或难治性失神癫痫的疗效研究
V Soto-Insuga,E González-Alguacil,V Cantarín Extremera et al.
V Soto-Insuga et al.
Introduction: Previous research suggests that amantadine could be effective as an antiepileptic drug. We evaluate the use of the drug in children with refractory generalised epilepsy. ...
Cross-cultural adaptation and validation of the Spanish-language version of the Allodynia Symptom Checklist (ASC-12) in patients with primary headaches [0.03%]
原发性头痛患者的西班牙语版触诱发痛症状检查表(ASC-12)的跨文化改编和验证
G Bertotti,A Gil-Martínez,J Rodríguez-Vico et al.
G Bertotti et al.
Introduction: Cutaneous allodynia has been described in primary headaches. The 12-item Allodynia Symptom Checklist (ASC-12) is a valid, reliable scale for assessment in the population with migraine. No Spanish-language ve...
EEG in nonconvulsive status epilepticus: The influence of clinical information [0.03%]
脑电图在非惊厥持续状态中的影响及临床信息的作用
A Horrillo-Maysonnial,B Echeveste,J Iriarte et al.
A Horrillo-Maysonnial et al.
Introduction: Blind EEG analysis, especially in the case of suspected nonconvulsive status epilepticus (NCSE), can lead to misdiagnosis. It is important to consider patient demographic and clinical information when interp...
N Morato-Martín,M Ballesteros-Sánchez,L Martínez-Vicente et al.
N Morato-Martín et al.
Background: Wild-type transthyretin amyloidosis (ATTRwt amyloidosis) has traditionally been considered a purely cardiological condition. However, recent studies suggest that neurological involvement in ATTRwt amyloidosis ...
A cohort approach to focal cortical dysplasia type II: A 10-year management overview at an adult epilepsy referral centre [0.03%]
成人癫痫转诊中心局灶性皮质发育不良II型的队列管理概述十年回顾
A M Minguillón Pereiro,J García-de Soto,J Pouso-Diz et al.
A M Minguillón Pereiro et al.
Introduction: Focal cortical dysplasia (FCD) type II, or Taylor-type FCD, is considered a common cause of drug-resistant epilepsy, with specific characteristics. In many cases, these patients respond well to surgery. ...
Observational Study
Neurologia. 2026 May;41(4):501937. DOI:10.1016/j.nrleng.2026.501937 2026
Multidisciplinary management of X-linked myotubular myopathy in Spain and Portugal: A case series analysis [0.03%]
西班牙和葡萄牙的X连锁肌管肌病的多学科管理：病例系列分析
D Gómez-Andrés,F Munell,S I Pascual Pascual et al.
D Gómez-Andrés et al.
Introduction: X-linked myotubular myopathy (XLMTM) is a severe, rare, familial neuromuscular disease caused by mutations in the MTM1 gene. XLMTM presents a wide spectrum of clinical manifestations, including neuromuscular...
The Parkinson's Real-World Impact Assessment (PRISM) project in the management and burden of Parkinson's disease in Spain [0.03%]
西班牙帕金森病管理负担的帕金森病实际影响评估（PRISM）项目
C Painous Martí,I Pijuan Jiménez,À Bayés Rusiñol et al.
C Painous Martí et al.
Introduction: Real-world data studies are a promising option for understanding everyday Parkinson's disease (PD) management and optimizing strategies and therapeutic options. The Parkinson's Real-World Impact Assessment (...
Redefining therapeutics in vATTR: Evaluation of response predictors to tafamidis and patisiran treatment in a non-endemic area. A proposal for a novel individualised therapeutic approach [0.03%]
在vATTR治疗中的重新定义：tafamidis和patisiran治疗反应预测因子的评估（非地方性区域）。新型个体化治疗方法的建议
L Martínez-Vicente,V Gajate-García,G Gutiérrez-Gutiérrez et al.
L Martínez-Vicente et al.
Introduction: Hereditary transthyretin amyloidosis (vATTR) is a progressive genetic disorder with several approved treatments. We investigated treatment responses to tafamidis and patisiran in vATTR patients to identify p...